Showing results (401-410 of 671) with videos related to

Sort By:
Pageof 68
Annals of Hematology|March 14, 2018
Treatment of late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: the role of corticosteroidsXiao-Dong Mo, Xiao-Hui Zhang, Lan-Ping Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2015
Interferon-α: A Potentially Effective Treatment for Minimal Residual Disease in Acute Leukemia/Myelodysplastic Syndrome after Allogeneic Hematopoietic Stem Cell TransplantationXiao-Dong Mo, Xiao-Hui Zhang, Lan-Ping Xu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2010
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis CChen-Hua Liu, Cheng-Chao Liang, Chun-Jen Liu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 6, 2007
Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance indexChen-Hua Liu, Shih-Jer Hsu, Jou-Wei Lin, et al.
Alimentary Pharmacology & Therapeutics|January 26, 2019
Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myelomaTung-Hung Su, Chun-Jen Liu, Tai-Chung Tseng, et al.
Alimentary Pharmacology & Therapeutics|December 29, 2018
Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infectionTung-Hung Su, Chun-Jen Liu, Tai-Chung Tseng, et al.
Annals of Hematology|March 13, 2017
Comparison of outcomes after donor lymphocyte infusion with or without prior chemotherapy for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantationXiao-Dong Mo, Xiao-Hui Zhang, Lan-Ping Xu, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 5, 2023
Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapyMeng-Ju Lin, Tung-Hung Su, Chun-Jen Liu, et al.
The American Journal of Gastroenterology|June 26, 2024
Pre-Existing and New-Onset Metabolic Dysfunctions Increase Cirrhosis and Its Complication Risks in Chronic Hepatitis BShang-Chin Huang, Tung-Hung Su, Tai-Chung Tseng, et al.
European Journal of Heart Failure|January 8, 2025
Metabolic dysfunction-associated steatotic liver disease is associated with increased risks of heart failureKai-Chun Chang, Tung-Hung Su, Cho-Kai Wu, et al.
Pageof 68